1Hahn-Ast C,Glasmacher A,Mückter S,et al.Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006[J].J Antimicrob Chemother,2010,65(4):761-768.
2Einsele H,Loeffler J.Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients[J].Clin Microbiol Infect,2008,14(Suppl 4):37-45.
3Buchheidt D,Hummel M,Schleiermacher D,et al.Prospective clinical evaluation of LightCycler-mediated polymerase chain reaction assay,a nested -PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients[J].Br J Haematol,2004,125(2):196-202.
4Cuenca-Estrella M,Meije Y,Diaz-Pedroche C,et al.Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia[J].J Clin Microbiol,2009,47(2):379-384.
5Cruzado M,Blanco JL,Durán C,et al.Evaluation of two PCR methodologies for the detection of Aspergillus DNA[J].Revlberoam Micol,2004,21(4):209-212.
6Garcia ME,Blanco JL,Caballero J,et al.Anticoagu-lants interfere with PCR used to diagnose invasive aspergillosis[J].J Clin Microbiol,2002,40(4):1567-1568.
7Tuon FF.A systematic literature review on the diag-nosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples[J].Revlberoam Micol,2007,24(2):89-94.
8Suarez F,Lortholary O,Buland S,et al.Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance[J].J Clin Microbiol,2008,46(11):3772-3777.
9Henry T,Iwen PC,Hinrichs SH.Identification of As-pergillus species using internal transcribed spacer regions 1 and 2[J].J Clin Microbiol,2000,38(4):1510-1515.
3Maschmeyer G,Vehreschild JJ,Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients [J]. Drugs, 2007,67 (11 ) : 1567-1601.
4White PL,Linton CJ,Perry MD,et al. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting [J]. Clin Infect Dis, 2006,42 (4) : 487-489.
5Svetlana Challier, Ste ' phanie Boyer, Eric Abachin, et al. Development of a Serum-Based Taqman Real- Time PCR Assay for Diagnosis of Invasive Aspergillosis [J]. J Clin Microbiol, 2004, 42 (2): 844- 846.
6Jordanides NE ,Allan EK ,McLintock LA ,et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in hematooncology patients [J]. Bone Marrow Transplant, 2005,35 (4) : 389-395.
7Sanguinetti M, Posteraro B, Pagano L,et al. Comparion of real-time PCR, concentional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis [J]. J Clin Microbiol, 2003,41 (8) : 3922-3925.
3Pfeiffer CD,Fine JP,Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay:a meta-analysis[J~. Clin Infect Dis, 2006,42(10): 1417-1427.
4Sulahian A,Porcher R,Bergeron A,et al. Use and limits of (1-3) β-d-glucan assay (Fungitell), compared to galactomannan deter ruination (Platelia Aspergilius), for diagnosis of invasive aspergil losis[J]. J Clin Microbiol,2014,52(7) :2328-2333.
5Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the(1>3)beta-D-glucan assay as an aid to diagnosis of fungal infections in humans[J]. Clin Infect Dis,2005, 41(5) :654-659.
6Khan ZU,Ahmad S,Theyyathel AM. Detection of aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally in- fected rats[J]. Mycoses,2008,51(2):129-135.
7Si YX,Zhang ZY, Wang YB. Radiological diagnosis of pulmonary fungal infections[J]. J Diagn Conc Prac, 2010,9 (2) : 116-119.
8Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenie patients at high risk for invasive fungal infection: a prospective feasibility study [J].Clin Infect Dis, 2005,41 (9) : 1242-1250.
